Decision-making support for Spanish-speaking Latina breast cancer survivors
Official title: Cultural and Linguistic Adaptation of a Breast Reconstruction Decision Tool - AIM2
Run by UNC Lineberger Comprehensive Cancer Center · NCT06817226 · Data updated 2026-11-12
This study is trying to help Spanish-speaking Latina breast cancer survivors make better decisions about breast reconstruction after surgery by gathering their input to improve a decision-making tool.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | October 10, 2024 |
| Main results expected | August 28, 2026 |
| Study ends | August 28, 2026 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT06817226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Spanish-speaking Latina women aged 18 and older who have a history of breast cancer and have undergone breast surgery within the last 8 years.
✕Probably not a fit
Patients who do not identify as Latina or who are not Spanish-speaking may not receive benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on improving decision-making for Spanish-speaking Latina women diagnosed with breast cancer, particularly regarding breast reconstruction after mastectomy. It aims to assess the decision-making context and solicit input from the target population to refine a decision aid that addresses their specific needs. By enhancing shared decision-making, the study seeks to increase the likelihood of these women receiving guideline-concordant treatment and improving their overall satisfaction with care.
Why it matters
Potential benefit: If successful, this study could empower Spanish-speaking Latina breast cancer survivors to make informed decisions about their treatment options, potentially improving their quality of life.
How similar studies have gone: Other studies have shown success in using decision aids to improve treatment decision-making in diverse populations, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Survivors: (must meet all criteria) * Female sex * Adult at least 18 years of age * Latina, Latino, or Latinx ethnicity - defined as born in or descending from South America, Mexico, Central America, other Spanish-speaking Caribbean islands * Prefer to receive health information in Spanish * Have a history of breast malignancy (e.g., ductal carcinoma, DCIS) or high risk for breast cancer (e.g., BRCA mutation) * Had breast surgery (Mastectomy/Lumpectomy/Mastectomy but no reconstruction) within the last 8 years * Able to understand an IRB-Approved consent information sheet Exclusion Criteria: \-
Where it's running
-
The University of North Carolina
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Clara Lee, MPP, MD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Victor Catalan Gallegos
- Email: victor.gallegos@med.unc.edu
- Phone: +1 919-966-3215
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.